Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0001628280-26-012468 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-24 | BLFS | GOSWAMI JOYDEEP | Dir | A - Grant | — | +8,170 | 53.2K | +18% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | A | A | 8,170 | — | 53,156 | D | — | — | (F1) The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026 |